Patrick Thomas Kennedy's most recent trade in Jazz Pharmaceuticals plc was a trade of 3,507 Ordinary Shares done . Disclosure was reported to the exchange on Aug. 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | Patrick Thomas Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 3,507 | 8,661 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Patrick Thomas Kennedy | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.25 per share. | 07 Aug 2025 | 1,959 | 6,702 (0%) | 0% | 111.3 | 217,940 | Ordinary Shares |
| Jazz Pharmaceuticals plc | Patrick Thomas Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2024 | 3,731 | 5,154 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Patrick Thomas Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 1,423 | 1,423 (0%) | 0% | 0 | Common Stock |